Silverarc Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Sell
48,101
-2,866
-6% -$548K 1.08% 31
2026
Q1
$9.34M Sell
50,967
-24,445
-32% -$4.5M 0.95% 28
2025
Q4
$13.3M Sell
75,412
-5,007
-6% -$818K 1.84% 18
2025
Q3
$11.3M Buy
+80,419
New +$10.9M 1.52% 22
2024
Q4
Sell
-19,940
Closed -$3.87M 68
2024
Q3
$3.87M Buy
19,940
+575
+3% +$120K 0.87% 36
2024
Q2
$4.49M Hold
19,365
1.06% 32
2024
Q1
$4.18M Sell
19,365
-635
-3% -$149K 1.16% 29
2023
Q4
$5.18M Sell
20,000
-8,069
-29% -$1.98M 1.54% 27
2023
Q3
$7.21M Buy
28,069
+1,215
+5% +$325K 2.19% 12
2023
Q2
$7.65M Buy
26,854
+15,543
+137% +$4.63M 2.37% 11
2023
Q1
$3.14M Sell
11,311
-10,664
-49% -$2.95M 1.3% 29
2022
Q4
$6.09M Buy
+21,975
New +$6.21M 1.74% 20
2022
Q3
Sell
-20,825
Closed -$4.25M 83
2022
Q2
$4.25M Buy
20,825
+10,577
+103% +$2.16M 1.31% 24
2022
Q1
$230K Buy
10,248
+4,504
+78% +$979K 0.1% 62
2021
Q4
$1.38M Buy
5,744
+1,355
+31% +$348K 0.56% 48
2021
Q3
$1.24M Buy
+4,389
New +$1.44M 0.7% 48
2021
Q2
Sell
-5,000
Closed -$1.4M 101
2021
Q1
$1.4M Buy
5,000
+2,000
+67% +$539K 0.76% 48
2020
Q4
$735K Buy
+3,000
New +$774K 0.43% 59

Other funds holding BIIB

Silverarc Capital Management's BIIB Position: Q2 2026 in Review

Silverarc Capital Management reduced its Biogen (BIIB) stake by 5.6% in Q2 2026, selling an estimated $548K and leaving 48,101 shares worth $10.4M. The position accounts for 1.08% of the portfolio, ranked #31.

Silverarc Capital Management first reported a position in BIIB in Q4 2020 and has held it in 18 quarters since. The position peaked at $13.3M in Q4 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Silverarc Capital Management held 48,101 shares of Biogen worth $10.4M as of Q2 2026.
  • Silverarc Capital Management sold 2,866 Biogen shares in Q2 2026, an estimated $548K.
  • Biogen made up 1.08% of Silverarc Capital Management's portfolio in Q2 2026, its #31 holding.
  • Silverarc Capital Management first reported a position in Biogen in Q4 2020 and has held it in 18 quarters since.
  • Silverarc Capital Management's Biogen position peaked at $13.3M in Q4 2025.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.